Particle-reinforced polymers are widely used in load-carrying applications. The effect of particle size on damage development in the polymer is still relatively unexplored. In this study, the effect of glass-sphere size on the damage development in tensile loaded epoxy has been investigated. The diameter of the glass spheres ranged from approximately 0.5-50 lm. The first type of damage observed was debonding at the sphere poles, which subsequently grew along the interface between the glass spheres and epoxy matrix. These cracks were observed to kink out into the matrix in the radial direction perpendicular to the applied load. The debonding stresses increased with decreasing sphere diameter, whereas the length to diameter ratio of the resulting matrix cracks increased with increasing sphere diameter. These effects could not be explained by elastic stress analysis and linear-elastic fracture mechanics. Possible explanations are that a thin interphase shell may form in the epoxy close to the glass spheres, and that there is a length-scale effect in the yield process which depends on the strain gradients. Cohesive fracture processes can contribute to the influence of sphere size on matrix-crack length. Better knowledge on these underlying size-dependent mechanisms that control damage development in polymers and polymer composites is useful in development of stronger materials. From a methodology point of view, the glass-sphere composite test can be used as an alternative technique (although still in a qualitative way) to hardness vs. indentation depth to quantify length-scale effects in inelastic deformation of polymers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.